NCT03400150 - BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007 | Biotech Hunter

Enrollment

222

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions

Prostate Cancer

Interventions

DEVICE

balloon

balloon implantation

OTHER

Control

Control - Marking \& IMRT are standard of care for prostate cancer - there is no study-specific intervention

Trial Locations (16)

New York University Langone Health, New York

Advanced Radiation Center of New York, Lake Success

Chesapeake Urology Research Associates, Owings Mills

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

Medical University of South Carolina (MUSC), Charleston

Advanced Urology Institute, Daytona Beach

Rush University Cancer Center, Chicago

Urology Nevada, Reno

KSK Medical Center, Irvine

Western Radiation Oncology, Apple Valley

Assuta Ashdod, Ashdod

Rabin Medical Center, Petah Tikva

Maastro, Maastricht

Institute of Maria Skłodowska-Oncology Centre, Warsaw

CUF Porto Instituto, Porto

Beatson West of Scotland Cancer Centre, Glasgow